Suppr超能文献

在接受环磷酰胺、阿霉素和放疗治疗乳腺癌后继发的治疗相关急性髓系白血病中出现7号染色体长臂缺失、20号染色体长臂缺失和16号染色体倒位:一例报告

The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report.

作者信息

Yonal Ipek, Hindilerden Fehmi, Ozcan Erkan, Palanduz Sukru, Aktan Melih

机构信息

Istanbul University Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey.

出版信息

J Med Case Rep. 2012 Feb 16;6:67. doi: 10.1186/1752-1947-6-67.

Abstract

INTRODUCTION

Therapy-related acute myeloid leukemia occurs as a complication of treatment with chemotherapy, radiotherapy, immunosuppressive agents or exposure to environmental carcinogens.

CASE PRESENTATION

We report a case of therapy-related acute myeloid leukemia in a 37-year-old Turkish woman in complete remission from breast cancer. Our patient presented to our facility with fatigue, fever, sore throat, peripheral lymphadenopathy, and moderate hepatosplenomegaly. On peripheral blood and bone marrow aspirate smears, monoblasts were present. Immunophenotypic analysis of the bone marrow showed expression of CD11b, CD13, CD14, CD15, CD33, CD34, CD45 and human leukocyte antigen-DR, findings compatible with the diagnosis of acute monoblastic leukemia (French-American-British classification M5a). Therapy-related acute myeloid leukemia developed three years after adjuvant chemotherapy consisting of an alkylating agent, cyclophosphamide and DNA topoisomerase II inhibitor, doxorubicin and adjuvant radiotherapy. Cytogenetic analysis revealed a 46, XX, deletion 7 (q22q34), deletion 20 (q11.2q13.1) karyotype in five out of 20 metaphases and inversion 16 was detected by fluorescence in situhybridization. There was no response to chemotherapy (cytarabine and idarubicin, FLAG-IDA protocol, azacitidine) and our patient died in the 11th month after diagnosis.

CONCLUSIONS

The median survival in therapy-related acute myeloid leukemia is shorter compared to de novoacute myeloid leukemia. Also, the response to therapy is poor. In therapy-related acute myeloid leukemia, complex karyotypes have been associated with abnormalities of chromosome 5, rather than 7. To the best of our knowledge, this is the first case of therapy-related acute myeloid leukemia showing the co-presence of deletion 7q, 20q and the inversion 16 signal.

摘要

引言

治疗相关的急性髓系白血病是化疗、放疗、免疫抑制剂治疗或接触环境致癌物后的并发症。

病例报告

我们报告一例37岁的土耳其女性患者,该患者乳腺癌已完全缓解,却发生了治疗相关的急性髓系白血病。我们的患者因疲劳、发热、咽痛、外周淋巴结肿大和中度肝脾肿大前来我院就诊。外周血和骨髓涂片可见原单核细胞。骨髓免疫表型分析显示CD11b、CD13、CD14、CD15、CD33、CD34、CD45和人类白细胞抗原-DR表达,这些结果符合急性单核细胞白血病(法美英分类M5a)的诊断。治疗相关的急性髓系白血病发生在辅助化疗三年后,辅助化疗包括烷化剂环磷酰胺、DNA拓扑异构酶II抑制剂阿霉素及辅助放疗。细胞遗传学分析显示,20个中期细胞中有5个的核型为46, XX, 7号染色体缺失(q22q34)、20号染色体缺失(q11.2q13.1),荧光原位杂交检测到16号染色体倒位。化疗(阿糖胞苷和伊达比星,FLAG-IDA方案,阿扎胞苷)无效,患者在诊断后第11个月死亡。

结论

与原发性急性髓系白血病相比,治疗相关的急性髓系白血病中位生存期较短。而且,对治疗的反应较差。在治疗相关的急性髓系白血病中,复杂核型与5号染色体异常有关而非7号染色体。据我们所知,这是首例显示7q、20q缺失及16号染色体倒位信号同时存在的治疗相关急性髓系白血病病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc7c/3327634/a403f99572d2/1752-1947-6-67-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验